Rosiglitazone - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Rosiglitazone



  
 Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: results suggest improvements in lipoatrophy ...
Whether the outcomes are similar with long-term rosiglitazone therapy remains to be shown.
In our study, the patients receiving stavudine therapy did not show an increase in subcutaneous adipose tissue with rosiglitazone, which may explain the lack of efficacy in previous studies that had a baseline imbalance and overuse of stavudine in the rosiglitazone group (18, 19).
Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: results suggest improvements in lipoatrophy associated with rosiglitazone.
http://www.natap.org/2005/HIV/090605_04.htm   (4089 words)

  
 MedlinePlus Drug Information: Rosiglitazone (Systemic)
Other medicines—Do not take other medicines during the time you are taking rosiglitazone unless they have been discussed with your doctor.
Children—Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of rosiglitazone in children with use in other age groups.
When you are taking rosiglitazone, it is especially important that your doctor and pharmacist know if you are taking any of the following:
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500022.html   (1661 words)

  
 EHS: Mosby's Drug Consult - Drug Updates - Rosiglitazone Maleate and Metformin Hydrochloride 003571
The following recommendations regarding the use of Avandamet in patients inadequately controlled on rosiglitazone and metformin monotherapies are based on clinical practice experience with rosiglitazone and metformin combination therapy.
Additional efficacy and safety information about rosiglitazone and metformin monotherapies may be found in the prescribing information for each individual drug.
In rosiglitazone and metformin combination studies, efficacy was demonstrated with no gender differences in glycemic response.
http://www.mosbysdrugconsult.com/DrugConsult/003571.html   (8765 words)

  
 rosiglitazone news articles
Rosiglitazone (Avandia), troglitazone (Rezulin), and pioglitazone (ACTOS) are part of a group of medications called thiazolidinediones.
Rosiglitazone, marketed as Avandia, was given to test subjects for 12 weeks without changing their current medications.
These include switching anti-HIV drugs and the use of drugs such as rosiglitazone and metformin to directly treat body fat changes.
http://www.mongabay.com/drugs/drugs/rosiglitazone.html   (3111 words)

  
 MedlinePlus Drug Information: Rosiglitazone
You will have these tests before you begin to take rosiglitazone, and then every 2 months for the first year of therapy.
tell your doctor and pharmacist if you are allergic to rosiglitazone, pioglitazone, troglitazone, or any other drugs.
Your blood sugar and glycosolated hemoglobin (HbA1c) should be checked regularly to determine your response to rosiglitazone.
http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a699023.html   (965 words)

  
 Aidsmap Rosiglitazone causes lipomas in HIV-positive man with fat loss
The investigators recommend that rosiglitazone “therapy should be approached with caution in patients with HIV-associated lipoatrophy.”
However one randomised study found no effect of rosiglitazone on peripheral fat loss.
Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy.
http://www.aidsmap.com/en/news/BFCBC4E1-FC92-486A-9E95-68EADEE2D66E.asp   (677 words)

  
 Kuriakose B, Dolovich L. The addition of rosiglitazone to metformin improves glycemic control in patients with type 2 ...
Further investigations need to be performed to assess whether rosiglitazone (and its counterpart pioglitazone) have a more extensive place in therapy.
Thus, when compared to placebo, the HbA1C after 26 weeks of therapy was 1% and 1.2% lower in the rosiglitazone 4 mg and 8 mg groups, respectively.
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
http://www.informedpharmacotherapy.com/Issue4/EBP/Kuriakose_and_Dolovich.htm   (1184 words)

  
 Rosiglitazone for ulcerative colitis study Q & A
As a result, the only way to determine if rosiglitazone will help treat ulcerative colitis is to conduct a study such as this.
In our preliminary studies in humans with ulcerative colitis that had not responded to any other therapy, more than half of the patients had improved symptoms within 12 weeks after starting treatment with rosiglitazone.
In several studies, animals treated with rosiglitazone recovered more quickly from experimental colitis than those that were not treated with rosiglitazone.
http://www.rucstudy.org/qa.html   (1235 words)

  
 Rosiglitazone - Wikipedia, the free encyclopedia
Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class.
Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFκB) levels fall and inhibitor (IκB) levels increase in patients on rosiglitazone (Mohanty et al).
Rosiglitazone is a pure ligand of PPARγ, and has no PPARα-binding action.
http://en.wikipedia.org/wiki/Rosiglitazone   (179 words)

  
 Diabetes Monitor - rosiglitazone (Avandia)
Three of the 10 patients who developed cardiac failure had no known prior evidence of CHF or preexisting cardiac condition.
Avandia (rosiglitazone) is a thiazolidinedione medication for the therapy of
The use of Avandia (rosiglitazone maleate) in combination therapy with insulin is also indicated.
http://www.diabetesmonitor.com/avandia.htm   (705 words)

  
 Rosiglitazone
If you have an allergy to rosiglitazone or any other part of the medicine.
If you have active liver disease or yellowing (jaundice) during troglitazone therapy.
http://www.umm.edu/altmed/ConsDrugs/Rosiglitazonecd.html   (580 words)

  
 EASD: Rosiglitazone Works By Reducing Insulin Resistance
After 26 weeks, the combination of sulphonylurea and rosiglitazone led to an increase in function of 63 percent, compared with sulphonylurea therapy and placebo.
Data was pooled from three multicentre, double-blind studies of rosiglitazone as monotherapy in 2,090 patients.
Investigators compared rosiglitazone with a sulphonylurea (a traditional oral anti-diabetes medicine) in 231 patients previously treated with diet and exercise alone.
http://www.pslgroup.com/dg/132FFA.htm   (859 words)

  
 News - Gemfibrozil Increases Plasma Concentrations of Rosiglitazone
Considerable variability between individuals in the extent of drug interaction was noted, with the relative increase in rosiglitazone concentration ranged from 51 to 179%.
The researchers recommend that rosiglitazone dose be reduced by about 50 to 70% if gemfibrozil treatment is started on a patient using rosiglitazone, and the patient carefully monitored for signs and symptoms of adverse effects.
Administration of usual therapeutic doses of gemfibrozil considerably increases the plasma concentrations of rosiglitazone, an insulin-sensitising drug used to treat patients with Type 2 diabetes mellitus.
http://docguide.com/news/content.nsf/news/8525697700573E1885256D7A002EBB4A   (519 words)

  
 FDA Approves Rosiglitazone to Treat Type II Diabetes
In clinical studies of patients treated with rosiglitazone, by contrast, there was no evidence of drug-induced hepatotoxicity.
In general, rosiglitazone was well-tolerated in clinical studies.
In clinical trials, involving more than 4000 patients previously treated with diet alone or with metformin, rosiglitizone was shown to improve patients' ability to utilize insulin produced in the body.
http://www.fda.gov/bbs/topics/ANSWERS/ANS00957.html   (474 words)

  
 rosiglitazone (Avandia) - drug class, medical uses, medication side effects, and drug interactions by MedicineNet.com
PREGNANCY: There are no adequate studies of rosiglitazone in pregnant women.
rosiglitazone (Avandia) - drug class, medical uses, medication side effects, and drug interactions by MedicineNet.com
Studies using rosiglitazone, 4-8 mg per day, did not cause changes in blood levels of the commonly-used drugs, digoxin and warfarin.
http://www.medicinenet.com/rosiglitazone/article.htm   (881 words)

  
 Fact Sheets > Drugs and Medications > Avandia or Rosiglitazone
Be sure to consult your doctor before making any major medical decision.
Fact Sheets > Drugs and Medications > Avandia or Rosiglitazone
Avandia, in addition to diet and exercise, improves blood sugar control in adults with type 2 (non-insulin-dependent) diabetes.
http://www.fact-sheets.com/health/drugs-medications/avandia   (511 words)

  
 Once- and Twice-Daily Dosing With Rosiglitazone Improves Glycemic Control in Patients WIth Type 2 Diabetes (NDEI.ORG)
There was no evidence of hepatotoxicity in any treatment group.
Approximately 33% of drug-naive patients treated with rosiglitazone achieved1c
were observed in drug-naive patients at all rosiglitazone doses and in patients previously treated with oral monotherapy at rosiglitazone 8 mg o.d.
http://www.ndei.org/v2/website/litalerts/article.cfm?article_id=266   (385 words)

  
 Patient Education - Rosiglitazone (Avandia)
There have been no problems with interactions with other medicines.
Your medical provider has prescribed Rosiglitazone to treat your diabetes.
Most people experience no side effects from Rosiglitazone.
http://www.alaska.net/~akdm/Clinical/patient_ed/rosiglit_pat_ed.htm   (502 words)

  
 News - Rosiglitazone Could Have Antiinflammatory Effects
"These observations may have implications for long-term atherogenesis in subjects treated with rosiglitazone and possibly with other thizolidinediones," they add.
After 6 weeks of rosiglitazone therapy, plasma TNF-á and SAA were significantly inhibited in obese nondiabetic subjects but not in obese diabetic patients.
Eight obese nondiabetic subjects and 5 obese diabetic patients who did not receive rosiglitazone treatment were included as controls.
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256EAE00241B60   (510 words)

  
 Rosiglitazone, Avandia at PharmacyWanted.com
Continue to take rosiglitazone and talk to your doctor if you experience:
These may be early symptoms of heart problems.
Rosiglitazone may also be used with a sulfonylurea (e.g., Diabeta, Glucotrol, Micronase, others), metformin (Glucophage), or insulin when diet and exercise plus any one of these medicines alone do not result in adequate blood sugar control.
http://www.pharmacywanted.com/rosiglitazone-avandia.php   (993 words)

  
 Avandia and Avandamet type 2 diabetes medication
Very rarely, some patients have experienced vision changes due to swelling in the back of the eye while taking rosiglitazone, a component of Avandaryl.
If you experience an unusually rapid increase in weight, swelling, shortness of breath, or have a history of these conditions, talk to your doctor immediately.
In combination with insulin rosiglitazone, one of the components of Avandaryl, may increase the risk of other heart problems.
http://www.avandia.com   (864 words)

  
 Avandia - Drugs & Vitamins - Drug Library - DrugDigest
Check with your health care professional before stopping or starting any of your medicines.
Check with your prescriber or health care professional if your blood sugar is high, you may need a change of dose of rosiglitazone.
If you are going to have surgery, tell your prescriber or health care professional that you are taking rosiglitazone.
http://www.drugdigest.org/DD/DVH/Uses/0,3915,732Avandia,00.html   (710 words)

  
 Evidence for a Potent Antiinflammatory Effect of Rosiglitazone -- Mohanty et al. 89 (6): 2728 -- Journal of Clinical ...
Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: A Randomized Trial
Resistin Levels in Human Immunodeficiency Virus-Infected Patients with Lipoatrophy Decrease in Response to Rosiglitazone
atherogenesis in the long term in subjects treated with rosiglitazone
http://jcem.endojournals.org/cgi/content/abstract/89/6/2728   (812 words)

  
 The Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes -- Strowig and Raskin 28 (7): 1562 -- Diabetes ...
in subjects taking rosiglitazone (77.5 ± 28.6 to 75.3
rosiglitazone in the treatment of overweight subjects with type
effect of rosiglitazone occurred in subjects with more pronounced
http://care.diabetesjournals.org/cgi/content/abstract/28/7/1562   (378 words)

  
 Rosiglitazone Induction of Insig-1 in White Adipose Tissue Reveals a Novel Interplay of Peroxisome ...
Levels of Insig-1 mRNA were normalized to 36B4 and then expressed relative to vehicle-treated animals at the same time point.
Relative levels of Insig-1 mRNA were determined by real-time PCR of cDNAs prepared from RNA pooled from each treatment group (n = 7) as in A.
in liver following rosiglitazone treatment but to a lesser extent
http://www.jbc.org/cgi/content/full/279/23/23908   (4081 words)

  
 Rosiglitazone Significantly Increases Triglyceride and Cholesterol Levels and Does Not Improve HAART-associated ...
Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
There are no controlled studies of glitazones in patients with HAART-associated lipodystrophy (HAL).
The authors conclude, “Contrary to data in other patient groups, rosiglitazone did not increase subcutaneous fat in patients with HAL after 24 weeks of treatment.
http://www.hivandhepatitis.com/recent/metabolic/dyslipidemias/082903b.html   (347 words)

  
 ROSIGLITAZONE
Some drugs taken together may have interactions that cause illness or impair the effectiveness of the drugs.
It is a good idea to always check with your study clinician before taking any other medications, prescription or otherwise, to be sure it will not interact with rosiglitazone.
Rosiglitazone is a medication that is commonly used to help control blood sugar in people with diabetes.
http://depts.washington.edu/actu/drugs/rosiglitazone.htm   (322 words)

  
 GlaxoSmithKline Clinical Trial Register - Rosiglitazone Studies
A multi-center, open-label extension study to assess the safety and efficacy of rosiglitazone as monotherapy or in combination with concurrent metformin or sulphonylurea therapy when administered to patients with type 2 diabetes.
A post-marketing surveillance study of Avandia (Rosiglitazone) in the treatment of Filipino patients with type 2 diabetes
A multi-center, open-label study to assess the safety and efficacy of rosiglitazone (RSG) as monotherapy or in combination therapy with concurrent Metformin (Met) or Sulphonylurea (SU) when administered to Chinese patients with Type 2 diabetes.
http://ctr.gsk.co.uk/Summary/Rosiglitazone/StudyList.asp   (4420 words)

  
 Effect of Rosiglitazone on the Differential Expression of Diabetes-associated Proteins in Pancreatic Islets of C57Bl/6 ...
and the expression pattern was normalized by rosiglitazone treatment.
Recently, insulin sensitizer drugs, such as BRL49653 (rosiglitazone),
The insulin sensitizer drug, rosiglitazone, has been shown to
http://www.mcponline.org/cgi/content/full/1/7/509   (4385 words)

  
 Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-Gamma, Inhibits the Jun NH(2)-Terminal Kinase/Activating ...
This study was conducted to evaluate whether treatment of normal and diabetic rat hearts with rosiglitazone, a high-affinity ligand of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) used for the treatment of type 2 diabetes, improves postischemic functional recovery.
A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes
In a chronic protocol in which rosiglitazone was given by daily gavage (10 micromol/kg body wt) immediately after STZ injection, rosiglitazone also prevented postischemic injury and significantly improved functional recovery.
http://www.ndei.org/v2/website/litalerts/article.cfm?article_id=505   (339 words)

  
 Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients ...
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers
In this study, we assessed the effect of rosiglitazone on common
Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes Mellitus
http://atvb.ahajournals.org/cgi/content/abstract/24/5/930   (599 words)

  
 New Data Show Avandia(R) (rosiglitazone maleate) May Reduce Blood Pressure, an Important Cardiovascular Risk Factor, in ...
According to the American Heart Association, patients with type 2 diabetes are two to four times more likely to develop cardiovascular disease.
New Data Show Avandia(R) (rosiglitazone maleate) May Reduce Blood Pressure, an Important Cardiovascular Risk Factor, in Type 2 Diabetes Patients - Forbes.com
New Data Show Avandia(R) (rosiglitazone maleate) May Reduce Blood Pressure, an Important Cardiovascular Risk Factor, in Type 2 Diabetes Patients
http://www.forbes.com/prnewswire/feeds/prnewswire/2005/06/11/prnewswire200506111300PR_NEWS_B_MAT_NY_NYSA001.html   (1394 words)

  
 79 - Abstract (11th CROI)
Rosiglitazone for the Treatment of HIV Lipoatrophy: A Double-blind, Placebo-controlled, 48-week Trial
Conclusions:  RSG 4 mg bid for 48 weeks did not improve lipoatrophy in HIV-infected adults receiving antiretroviral therapy, despite significantly improving insulin sensitivity and plasma adiponectin levels.
Thiazolidinediones such as rosiglitazone (RSG) promote subcutaneous fat growth, decrease visceral fat, and improve glycemic and lipid parameters in type 2 diabetics and in adults with congenital LD, and reverse protease inhibitor (PI) toxicity to adipocytes in vitro.
http://www.retroconference.org/2004/cd/Abstract/79.htm   (389 words)

  
 Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation -- Ali et al. 146 ...
rosiglitazone for 28 d exhibited bone loss associated with an
However, rosiglitazone had no effect on osteoblastic cells at
Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
http://endo.endojournals.org/cgi/content/abstract/146/3/1226   (337 words)

  
 Diabetes (type 2) - rosiglitazone (No. 9) - obsolete, replaced by No. 63
Want to read our guidance on an illness or condition?
Diabetes (type 2) - rosiglitazone (No. 9) - obsolete, replaced by No. 63
Note: This guidance has now been replaced by No.
http://www.nice.org.uk/cat.asp?c=8079   (54 words)

  
 Effect of rosiglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2 on bleomycin-induced lung injury -- Genovese et al. ...
Effect of rosiglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2 on bleomycin-induced lung injury -- Genovese et al.
http://erj.ersjournals.com/cgi/content/abstract/25/2/225   (290 words)

  
 Arch Ophthalmol -- Rosiglitazone-Induced Proptosis, January 2005, Levin et al. 123 (1): 119
Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.
Rosiglitazone maleate belongs to the class of thiazolidinedione
http://archopht.ama-assn.org/cgi/content/extract/123/1/119   (117 words)

  
 15d-PGJ2 and Rosiglitazone Suppress Janus Kinase-STAT Inflammatory Signaling through Induction of Suppressor of ...
15d-PGJ2 and Rosiglitazone Suppress Janus Kinase-STAT Inflammatory Signaling through Induction of Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 in Glia -- Park et al.
and Rosiglitazone Suppress Janus Kinase-STAT Inflammatory Signaling through Induction of Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 in Glia
http://www.jbc.org/cgi/content/abstract/278/17/14747   (701 words)

  
 Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of ...
Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes -- McTernan et al.
determine the in vitro effects of insulin and rosiglitazone
Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes
http://jcem.endojournals.org/cgi/content/full/88/12/6098   (5216 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.